ProCE Banner Activity

Principais estudos de VIH que influenciam a minha prática após o CROI 2022

Slideset Download
Leia os resumos dos principais estudos de VIH dos membros do corpo docente especialistas do CROI 2022, incluindo resultados de estudos de estratégias de prevenção, terapias de ação prolongada, terapias de segunda linha, comorbidades e cura.

Released: March 18, 2022

Expiration: March 17, 2023

No longer available for credit.

Share

Faculty

Monica Gandhi

Monica Gandhi, MD, MPH

Professor of Medicine
Division of HIV, Infectious Diseases, and Global Medicine
Medical Director, Ward 86 HIV Clinic
University of California, San Francisco
San Francisco, California

Daniel R. Kuritzkes

Daniel R. Kuritzkes, 医学博士

科长,传染病科
布莱根妇女医院
Harriet Ryan Albee 医学教授
哈佛医学院
波士顿,马萨诸塞州

Babafemi Taiwo

Babafemi Taiwo, MBBS

Assistant Professor
Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, Illinois

David A. Wohl

David A. Wohl, MD

Professor of Medicine
School of Medicine
Site Leader, Global Clinical Trials Unit-Chapel Hill
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Cepheid

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

Merck & Co., Inc.

ViiV Healthcare

Faculty Disclosure

Primary Author

Monica Gandhi, MD, MPH

Professor of Medicine
Division of HIV, Infectious Diseases, and Global Medicine
Medical Director, Ward 86 HIV Clinic
University of California, San Francisco
San Francisco, California

Monica Gandhi, Médica, MPH, não tem conflitos de interesse relevantes a relatar.

Daniel R. Kuritzkes, 医学博士

科长,传染病科
布莱根妇女医院
Harriet Ryan Albee 医学教授
哈佛医学院
波士顿,马萨诸塞州

Daniel R. Kuritzkes, Médico, informou ter recebido fundos para apoio à investigação da Gilead Sciences, Merck, Novartis e ViiV Healthcare, bem como honorários por consultoria da Abpro, Atea, Decoy, Gilead Sciences, GlaxoSmithKline, Janssen. Merck, ViiV Healthcare e ViroStatics.

Babafemi Taiwo, MBBS

Assistant Professor
Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Babafemi Taiwo, MBBS, revelou que recebeu honorários de consultoria da Gilead Sciences, Merck e ViiV Healthcare/GSK e fundos para contratados independentes da Johnson & Johnson.

David A. Wohl, MD

Professor of Medicine
School of Medicine
Site Leader, Global Clinical Trials Unit-Chapel Hill
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

David A. Wohl, Médico, revelou que recebeu fundos para apoio à pesquisa da Gilead Sciences e Merck e honorários de consultoria da Gilead Sciences, Janssen, Merck e ViiV.